Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers
Frontiers in Pharmacology · 28.03.2025 · 16
DOI: 10.3389/fphar.2025.1562167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 28.03.2025. Verfasst von Qingmei Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hainan General Hospital and Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inhibitors of Apoptosis Proteins (IAPs) are a family of anti-apoptotic proteins that play a pivotal role in apoptosis in general but also as oncoproteins in cancer progression and, more importantly, drug resistance. IAPs enable cancer cells to evade programmed cell death and adapt to therapeutic stress by inhibiting pro-apoptotic caspase activity as well as modulating pivotal survival pathways. Recent advancements in targeting IAPs, particularly through the use of SMAC (second mitochondria-derived activator of caspase) mimetics and other small-molecule antagonists or inhibitors, have opened new avenues for overcoming drug resistance in cancers. The current review attempted to summarize the status quo of IAPs’ role in promoting chemotherapeutic drug resistance in various cancer treatments and discuss the most recent development of IAP-targeting therapies, particularly small-molecule inhibitors including their combinational strategies to enhance the sensitivity or achieve synergism to existing therapeutics. Additionally, we also outline the challenges and offer future perspectives for optimizing IAP-targeted approaches to improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hainan General Hospital and Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
- Hubei Province Key Laboratory of Traditional Chinese Medicine Resource and Chemistry, Department of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
- The Fifth People's Hospital of Hainan Province and Affiliated Dermatology Hospital of Hainan Medical University, Haikou, Hainan, China.
Zitieren
APA
Ye, Q., Zhuang, X. Z., Li, J., & Zhou, X. (2025). Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1562167
Vancouver
Ye Q, Zhuang XZ, Li J, Zhou X. Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1562167
BibTeX
@article{Ye2025,
author = {Ye, Qingmei and Zhuang, Xiao-Zhao and Li, Juan and Zhou, Xin},
title = {Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1562167}
}
EUVIMED